The efficiency of carbamazepine and oxcarbazepine in partial seizures;Parsiyel epilepsilerde karbamazepin ve okskarbazepin etkinliǧi

Turkiye Klinikleri Journal of Medical Sciences

Volumn 25, Issue 4, 2005, Pages 513-518

  Bozdemir, Hacer ^a   Aslan, Kezban ^a   Koç, Filiz ^a   Sarica, Yakup ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Carbamazepine; Epilepsy and prognosis; Oxcarbazepine; Partial

Indexed keywords

CARBAMAZEPINE; OXCARBAZEPINE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME;

EID: 24744448662     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ambrosio AF, Soares-Da-Silva P, Carvalho CM, Carvalho AP. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res 2002;27:121-30.
2. Arroyo S, Sander JW. Carbamazepine in comparative trials: Pharmacokinetic characteristics too often forgotten. Neurology 1999;53:1170-4.
3. Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology 2000;54:2237-44.
4. Beydoun A, Sachdeo RC, Rosenfeld WE, et al. Oxcarbazepine monotherapy for partial-onset seizures: A multicenter, double-blind, clinical trial. Neurology 2000;54:2245-51.
5. Sillanpaa M, Pihlaja T. Oxcarbazepine (GP 47 680) in the treatment of intractable seizures. Acta Paediatr Hung 1988-89;29:359-64.
6. Dam M. Oxcarbazepine in monotherapy. Behav Neurol 1990;3(Supp 1):31-4.
7. th ed. New York: Raven Press; 1995. p.987-95.
8. Dam M, Ekberg R, Loyning Y, Waltimo O, Jakobsen K. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989;3:70-6.
9. Sachdeo R, Beydoun A, Schachter S, et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 2001;57:864-71.
10. Isojarvi JI, Pakarinen AJ, Rautio A, Pelkonen O, Myllyla VV. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia 1994;35:1217-20.
11. Chapman K, Holland K, Erenberg G. Seizure exacerbation associated with oxcarbazepine in idiopathic focal epilepsy of childhood. Neurology 2003;61:1012-3.
12. Albani F, Grassi B, Ferrara R, Turrini R, Baruzzi A. PRIMO Study Group. Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. Seizure 2004;13:254-63.
13. Schmidt D, Sachdeo R. Oxcarbazepine for treatment of partial epilepsy: A review and recommendations is for clinical use. Epilepsy Behav 2000;1:396-405.
14. Rattya J, Vainionpaa L, Knip M, Lanning P, Isojarvi JI. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics 1999;103:588-93.
15. Vainionpaa LK, Mikkonen K, Rattya J, et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine or valproate monotherapy and after withdrawal of medication. Epilepsia 2004;45:197-203.
16. Wallace SJ. Newer antiepileptic drugs: Advantages and disadvantages. Brain Dev 2001;23:277-83.
17. Kutluay E, McCague K, D'Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 2003;4:175-80.
18. Wellington K, Goa KL. Oxcarbazepine: An update of its efficacy in the management of epilepsy. CNS Drugs 2001;15:137-63.